Men allegedly injured by testosterone therapy products are stepping forward. In January 2014, the FDA reported they were investigating the “risk of stroke, heart attack, and death in men taking FDA-approved testosterone products.” Since then, manufacturers of so-called “Low T” treatments like AndroGel, Testim, Depo-Testosterone,…
Men 65 years and older who take testosterone injections or use testosterone gel apparently have double the risk of suffering a heart attack as men who don’t. That was the conclusion of a PLOS One study, published in January 2014. Researchers also found that men…
A study released by the University of North Texas Health Center found an increased risk of brain damage among Caucasian men taking a form of testosterone therapy treatment. The article, published in the Journal of Alzheimer’s disease, came to the conclusion that “testosterone appears to…
Arkansas Attorney General Dustin McDaniel wants the Arkansas state Supreme Court to “reconsider its decision” in the case against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals, Inc. over Risperdal. According to an article in The Washington Times, the state claimed J&J and Janssen marketed…
In November 2013, the New York Times reported that Johnson & Johnson (J&J) would pay more than $2.2 billion in fines to settle claims that it overpromoted Risperdal, an antipsychotic drug, to vulnerable populations like the elderly, children, and adolescents. The company was accused of…
Perrigo Israel Pharmaceuticals is going to bat against the United States Food and Drug Administration (“FDA”) over its “failure” to announce the approval of a testosterone gel. Perrigo’s product, a generic testosterone gel 1% is bioequivalent to AbbVie’s Androgel. It was approved January 31, 2013…
Health experts recommend that doctors perform a physical exam along with a blood test to determine whether or not a man needs testosterone therapy treatment. In a study to be published in the Journal Urology, a lack of consistency was found in laboratory practices resulting…
Risperdal is approved by the FDA to treat irritability in children and young adults with autism. The FDA first approved this use in 2006 and was the first drug used to treat behaviors associated with autism. At that time, the FDA released results from controlled-trials…
On January 29, 2014, PLOS One published a new study on testosterone replacement and heart disease. According to researchers from the University of Texas, men 65 years and older who took testosterone injections or used testosterone gel had double the risk of going through a…
Johnson & Johnson (J&J), manufacturers of the antipsychotic drug Risperdal, was ordered in October 2010 to pay $257.7 million to the state of Louisiana for making misleading marketing claims about the drug. The company was said to have defrauded the Medicaid system by advertising Risperdal…
